Found 7 matching trials
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
PHASE2The purpose of this study is to evaluate the safety, efficacy, pharmacokine...
Location
UCSF Ron Conway Gateway Medical Building
A Study to Assess Pharmacokinetics, Safety, and Tolerability of Atumelnant in Healthy Japanese and Caucasian Participants
PHASE1The purpose of this study is to assess the PK profile, safety, and tolerabi...
Location
Crinetics Study Site
Drug-Drug Interaction Study of Atumelnant in Healthy Participants
PHASE1This study aims to evaluate the impact of strong CYP3A4 induction on the ph...
Location
Crinetics Study Site
A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia
PHASE3The purpose of this study is to evaluate the efficacy, safety, PK, and PD o...
Location
Crinetics Study Site
Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)
PHASE2The purpose of this Phase 2, open-label, sequential dose cohort study is to...
Location
Crinetics Study Site
An Extension Study to Evaluate Safety and Efficacy of Atumelnant in Participants With Congenital Adrenal Hyperplasia
PHASE2The purpose of this study is to evaluate the long-term safety, tolerability...
Location
Crinetics Study Site, Minneapolis, Minnesota 55454
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
PHASE1A Phase 1b/2a, first-in-disease, open-label, multiple-ascending dose explor...
Status
Active Not Recruiting
Location
National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)